|
|
|
|
| LEADER |
00000cam a2200000Ma 4500 |
| 001 |
EBOOKCENTRAL_ocn840309730 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o e |
| 007 |
cr nn||||||||| |
| 008 |
121227s1991 ne o 000 0 eng d |
| 040 |
|
|
|a I9W
|b eng
|e pn
|c I9W
|d OCLCQ
|d UV0
|d OCLCO
|d GW5XE
|d OCLCF
|d UA@
|d OCLCQ
|d EBLCP
|d OCLCQ
|d UAB
|d OCLCQ
|d UKAHL
|d K6U
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 935014369
|a 936332918
|a 1259422779
|
| 020 |
|
|
|a 9789401131346
|q (electronic bk.)
|
| 020 |
|
|
|a 9401131341
|q (electronic bk.)
|
| 020 |
|
|
|z 9780412361104
|
| 029 |
1 |
|
|a AU@
|b 000051668901
|
| 029 |
1 |
|
|a NZ1
|b 15014878
|
| 029 |
1 |
|
|a NZ1
|b 15593032
|
| 035 |
|
|
|a (OCoLC)840309730
|z (OCoLC)935014369
|z (OCoLC)936332918
|z (OCoLC)1259422779
|
| 050 |
|
4 |
|a RM1-950
|
| 082 |
0 |
4 |
|a 615
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Kruk, Zygmunt L.
|
| 245 |
1 |
0 |
|a Neurotransmitters and Drugs /
|c by Zygmunt L. Kruk, Christopher J. Pycock.
|
| 250 |
|
|
|a Third edition.
|
| 260 |
|
|
|a Dordrecht :
|b Springer Netherlands :
|b Imprint :
|b Springer,
|c 1991.
|
| 300 |
|
|
|a 1 online resource (216 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a 1 Neurotransmission: Sites at which drugs modify neurotransmission -- 1.1 The neurone -- 1.2 Axonal transport -- 1.3 Neuronal cell membranes -- 1.4 Precursors -- 1.5 Synthesis -- 1.6 Storage -- 1.7 Organelles and enzymes -- 1.8 Release -- 1.9 Receptors -- 1.10 Inactivation -- 1.11 Neurotransmitters or neuromodulators -- 1.12 Neurotransmitters in the nervous system -- 1.13 Neurotransmitters and drugs -- Further reading -- 2 Acetylcholine -- 2.1 Synthesis -- 2.2 Storage -- 2.3 Release -- 2.4 Cholinergic receptors -- 2.5 Inactivation of acetylcholine -- 2.6 Therapeutic applications and consequences of drugs acting at cholinergic synapses -- Further reading -- 3 Noradrenaline -- 3.1 Synthesis -- 3.2 Storage -- 3.3 Release -- 3.4 Adrenoreceptors -- 3.5 Inactivation of noradrenaline -- 3.6 Therapeutic applications and consequences of drugs acting at noradrenergic synapses -- Further reading -- 4 Dopamine -- 4.1 Synthesis -- 4.2 Storage -- 4.3 Release -- 4.4 Dopamine systems -- 4.5 Inactivation of dopamine -- 4.6 Therapeutic applications and consequences of drugs acting at dopaminergic synapses -- Further reading -- 5 5-Hydroxytryptamine -- 5.1 Synthesis -- 5.2 Storage -- 5.3 Release -- 5.4 5-HT receptors -- 5.5 Inactivation of 5-HT -- 5.6 Therapeutic applications and consequences of drugs acting at 5-HT synapses -- Further reading -- 6 Histamine -- 6.1 Synthesis -- 6.2 Storage -- 6.3 Release -- 6.4 Histamine receptors -- 6.5 Inactivation of histamine -- 6.6 Therapeutic applications and consequences of drug action on histamine systems -- Further reading -- 7 Inhibitory amino acids: GABA, glycine and taurine -- 7.1 Amino acids as neurotransmitters -- 7.2?-aminobutyric acid -- 7.3 Glycine -- 7.4 Taurine -- Further reading -- 8 Excitory amino acids: L-glutamic acid and L-aspartic acid -- 8.1 Synthesis -- 8.2 Storage -- 8.3 Release -- 8.4 Excitatory amino acid receptors in the CNS -- 8.5 Inactivation of released excitory amino acids -- 8.6 Functional roles of cerebral excitory amino acid neurotransmitters -- Further reading -- 9 Peptides and neuronal function -- 9.1 Peptides as neurotransmitters and hormones -- 9.2 Synthesis, storage, transport, release and inactivation of neuropeptides -- 9.3 Co-existence and co-transmission of peptides with classical neurotransmitters -- 9.4 Opioid peptides -- 9.5 Substance P (the tachykinins) -- 9.6 Cholecystokinin (CCK) -- 9.7 Vasoactive intestinal polypeptide -- 9.8 Neurotensin -- 9.9 Somatostatin -- 9.10 Bombesin -- Further reading.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Toxicology.
|
| 650 |
|
2 |
|a Medicine
|
| 650 |
|
2 |
|a Neurosciences
|
| 650 |
|
2 |
|a Toxicology
|
| 650 |
|
6 |
|a Médecine.
|
| 650 |
|
6 |
|a Neurosciences.
|
| 650 |
|
6 |
|a Toxicologie.
|
| 650 |
|
7 |
|a medicines (material)
|2 aat
|
| 650 |
|
7 |
|a toxicology.
|2 aat
|
| 650 |
|
7 |
|a medicine (discipline)
|2 aat
|
| 650 |
|
7 |
|a Medicine
|2 fast
|
| 650 |
|
7 |
|a Neurosciences
|2 fast
|
| 650 |
|
7 |
|a Toxicology
|2 fast
|
| 700 |
1 |
|
|a Pycock, Christopher J.
|
| 758 |
|
|
|i has work:
|a Neurotransmitters and drugs (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGHwHCpxgRrWfGjckKmtyq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Kruk, Zygmunt L.
|t Neurotransmitters and Drugs.
|d Dordrecht : Springer Netherlands, ©1991
|z 9780412361104
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3106276
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3106276
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH29669719
|
| 994 |
|
|
|a 92
|b IZTAP
|
